NGAL has been implicated in several pro-inflammatory and metabolic processes in animal models of conditions such as type 2 diabetes and non-alcoholic steatohepatitis [43,44]. The gene discussed is LCN2; the disease is metabolic dysfunction-associated steatohepatitis.